New scientific advances in gastroenterology presented at college's 68th annual meeting

October 08, 2003

WASHINGTON, DC (October 13, 2003) - Several of the world's preeminent gastroenterologists will gather from October 10 - October 15 for the American College of Gastroenterology's (ACG) 68th Annual Scientific Meeting at the Baltimore Convention Center in Baltimore, Maryland. The agenda includes the latest advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

Scientific presentations at the meeting will focus on new challenges in patient care faced by gastroenterologists and advances in the prevention and treatment of digestive diseases. Highlights of topics to be addressed include:

Two keynote addresses will highlight the program. The J. Edward Berk Distinguished Lecture, "Demystifying Motility: Gut Motor Dysfunction in Clinical Practice," will be delivered by Eamonn M.M. Quigley, M.D., FACG on Tuesday, October 14, 2003, at 10:10 AM (EDT). The Baker Presidential Lecture, "Reducing NSAID-Induced GI Injury: Keeping the GI Home at Night," will be presented by Loren A. Laine, M.D., FACG at 10:15 AM (EDT) on Wednesday, October 15, 2003.

Lunchtime media briefings are planned on the following topics:

Monday, October 13, 2002, 12:30 PM (EDT)
"Translating New Advances into Real Relief for IBS Sufferers"
Call-in number: 1-800-588-5167, access code 9944#Tuesday, October 14, 2003, 12:30 PM (EDT)
"Emerging Technologies in GI Diagnosis & Treatment: New But Improved?"
Call-in number: 1-800-588-5167, access code 9944#A press availability on the following topic is planned. Interviews may be scheduled in advance.

Monday, October 13, 2003, 3:30 PM (EDT)
"Emerging Data on NSAIDs, GI Complications & Implications for Clinical Practice"
The ACG was formed in 1932 to advance the scientific study and medical treatment of disorders of the gastrointestinal (GI) tract. The College promotes the highest standards in medical education and is guided by its commitment to meeting the needs of clinical gastroenterology practitioners. Consumers can get more information on GI diseases through the following ACG-sponsored programs:

American College of Gastroenterology

Related Irritable Bowel Syndrome Articles from Brightsurf:

Giant spider provides promise of pain relief for irritable bowel syndrome
Molecules from the venom of one of the world's largest spiders could help University of Queensland-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

An aspirin a day keeps the bowel doctor away
A regular dose of aspirin to reduce the risk of inherited bowel cancer lasts at least 10 years after stopping treatment, research has revealed.

Mindfulness program may benefit patients with irritable bowel syndrome
Adults with irritable bowel syndrome experienced fewer gastrointestinal symptoms after they participated in a mindfulness program meant to reduce stress.

The Lancet Gasteroenterology & Hepatology: First clinical trial finds probiotic treatment with dead bacteria is better than placebo at alleviating symptoms of irritable bowel syndrome
Probiotic bacteria that have been killed by heat can significantly improve symptoms of irritable bowel syndrome (IBS) compared to placebo, and are not associated with any safety risk, according to a new 12-week, randomized, double-blind, placebo-controlled clinical trial with 443 patients published in The Lancet Gastroenterology & Hepatology journal.

Are steroids used too much for patients with inflammatory bowel disease?
Steroid therapy is commonly used to treat acute attacks of the inflammatory bowel diseases ulcerative colitis and Crohn's disease; however, because it does not provide long-term benefits and it carries a risk of serious side effects, it should not be used to treat inflammatory bowel disease for more than three months.

New, noninvasive test for bowel diseases
Gut diseases such as inflammatory bowel disease (IBD) are increasingly prevalent worldwide, especially in industrialized countries.

HKBU discovers mechanisms underlying early life stress and irritable bowel syndrome
Researchers from Hong Kong Baptist University have found that the abnormal rise of a soluble protein called Nerve Growth Factor is a key factor linking early life stress to the development of irritable bowel syndrome.

Microbiome science may help doctors deliver more effective, personalized treatment to children with irritable bowel syndrome
To improve the treatment of children with irritable bowel syndrome (IBS), investigators have developed a sophisticated way to analyze the microbial and metabolic contents of the gut.

The Lancet Gastroenterology & Hepatology: Hypnotherapy could help relieve irritable bowel syndrome symptoms
Peer-reviewed / Randomised Controlled Trial / People Gut-directed hypnotherapy delivered by psychologists appears as effective in group or individual sessions, potentially offering a new treatment option for irritable bowel syndrome in primary and secondary care

Early source of irritable bowel syndrome discovered
Michigan State University scientists have identified an early cause of intestinal inflammation, one of the first stages of inflammatory bowel disease and irritable bowel syndrome, which afflict around 11 percent of the world's population.

Read More: Irritable Bowel Syndrome News and Irritable Bowel Syndrome Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to